What's the Problem? Cultural Capability and Learning from Historical Performance

Contains the cis-eQTLs with P value < 5 % for T-cells obtained from early undifferentiated arthritis patients. (TXT 1162 kb

Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s12325-017-0500-4"><b>here</b>.</a><br> <br> <strong>Provide enhanced digital features for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides<u></u></p

Additional file 1 of Assessing the usability of wearable devices to measure gait and physical activity in chronic conditions: a systematic review

Additional file 1: Table S1. List of factors assessed in both the quantitative and qualitative methods of usability assessment

Additional file 1 of Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa

Additional file 1: Fig. S1. Patient selection and categorization

Additional file 2 of Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa

Additional file 2: Table S1. Note review keyword terms

Additional file 1: of The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models

COPD-related medications. COPD-related treatments identified by pharmacy claims in the baseline period. (DOCX 27 kb

Additional file 4: of The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models

MSM sensitivity analyses for COPD-related medical costs. Sensitivity analyses conducted to test the robustness of findings to changes in model structure and assumptions. (DOCX 18 kb

Additional file 3: of The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models

Cohort counts by month of UMEC/VI initiation (N = 2200). Additional figure illustrating the number of patients initiating UMEC/VI each month. (DOCX 100 kb

Additional file 2: of The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models

Independent variables in treatment selection weighting models for cost analyses. Description of independent variables in treatment selection weighting models for the cost analyses. (DOCX 17 kb

MOESM1 of Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis

Additional file 1: Table S1. List of reagents used for flow cytometry analysis